Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

IRCCS National Neurological Institute "C. Mondino" Foundation

5 clinical trials · 5 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by IRCCS National Neurological Institute "C. Mondino" Foundation

RECRUITINGNCT06782074

Idiopathic Generalized Epilepsy Cognitive and Emotional Profile

The primary goal of the study is to explore the neurocognitive, emotional-behavioral functioning, and quality of life of adolescents with IGE, identifying key factors that affect...

Sponsor: IRCCS National Neurological Institute "C. Mondino" FoundationEnrolling: 961 location
EpilepsyQuality of LifeNeuropathology+2
RECRUITINGNCT06778772

Transition From Pediatric to Adult Epilepsy Care

The goal of this observational study is to assess the preparation of the caregiver and the patient for the transition, by comparing the results of the Transition Readiness...

Sponsor: IRCCS National Neurological Institute "C. Mondino" FoundationEnrolling: 901 location
Epilepsy
RECRUITINGNCT06882122

Neurophysiological and Biomolecular Effects of Atogepant in Episodic Migraine

The investigators aim to assess and compare neurophysiological and biochemical changes induced by a 3-month treatment with atogepant (60 mg daily) in patients with high-frequency...

Sponsor: IRCCS National Neurological Institute "C. Mondino" FoundationEnrolling: 301 location
Migraine DisorderEpisodic Migraine
RECRUITINGNCT06549270

Biochemical Profiling of Migraine Patients

Aim of the study was to assess a potential dysfunction of the endocannabidiome system (eCBome) in migraine patients. Migraine patients who will undergo preventive therapy with...

Sponsor: IRCCS National Neurological Institute "C. Mondino" FoundationEnrolling: 1001 location
Migraine DisordersChronic MigraineEpisodic Migraine
RECRUITINGNCT06562400

Searching for Novel Therapeutic Approaches in Migraine Patients Resistant to Treatments

Primary working hypothesis is that NON-responders to mAbs bear a dysfunction of the endocannabidiome system (eCBome), as suggested by pre-clinical and clinical data by our group....

Sponsor: IRCCS National Neurological Institute "C. Mondino" FoundationEnrolling: 451 location
Migraine DisordersChronic MigraineEpisodic Migraine